Drugs Made In America Acquisition (DMII) Shares Outstanding (Weighted Average) (2024 - 2025)

Drugs Made In America Acquisition (DMII) reported Shares Outstanding (Weighted Average) of $12.8 million for Q4 2025, up 2.55% year-over-year from $12.5 million in Q4 2024, and up 371.74% on a QoQ basis from $2.7 million in Q3 2025.

Drugs Made In America Acquisition (DMII) has 2 years of Shares Outstanding (Weighted Average) data on file, last reported at $12.8 million in Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 2.55% year-over-year to $12.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.8 million (up 2.55% YoY) and the FY2025 annual result came in at $12.8 million, up 2.55% from the prior year.
  • Shares Outstanding (Weighted Average) improved to $12.8 million in Q4 2025 per DMII's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $12.8 million in Q4 2025 and bottomed at $2.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 46.95 Mn
2 Berto Acquisition 316.66 Mn 316.66 Mn - 30.02 Mn
3 Centurion Acquisition 311.94 Mn 311.94 Mn - 28.75 Mn
4 Churchill Capital Corp IX 311.36 Mn 311.36 Mn - 28.75 Mn
5 Agriculture & Natural Solutions Acquisition 301.94 Mn 301.94 Mn - 26.65 Mn
6 Siddhi Acquisition Corp (Cayman Islands) 286.76 Mn 286.76 Mn - 27.60 Mn
7 Bold Eagle Acquisition 276.06 Mn 276.06 Mn - 25.80 Mn
8 Cartesian Growth Corp III 270.68 Mn 270.68 Mn - 20.60 Mn
9 Oyster Enterprises II Acquisition 266.84 Mn 266.84 Mn - 26.01 Mn
10 Drugs Made In America Acquisition 128.97 Mn 128.97 Mn - 12.82 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 12.82 Mn
Sep 30, 2025 2.72 Mn
Dec 31, 2024 12.50 Mn